NCT05442151View on ClinicalTrials.gov

Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts

NARecruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

May 9, 2022

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Neoplasms

Interventions

DRUG

PET/CT ([F-18]FAPI-74)

PET/CT using \[18F\] FAPI-74 injection

Trial Locations (1)

565-0871

RECRUITING

Osaka University Hospital, Suita

All Listed Sponsors

lead

Tadashi Watabe

OTHER